GlaxoSmithKline is celebrating as it emerges that the UK pharma giant triumphed in its legal battle against Reckitt Benckiser after accusing the rival firm of misleading consumers by directly comparing its product Nurofen to paracetamol in its advertising campaign, when GSK manufactures the branded version, Panadol.
GSK wins case against Reckitt Benckiser over misleading ad campaign
